Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06671652 · ClinicalTrials.gov registry record · NA
Adaptation and Implementation of a Cherokee-based Participatory Research Project to Reduce CVD Risk
A NA study of Blood Pressure, sponsored by University of Missouri-Columbia.
- Completed
- Registry status
- NA
- Development phase
- 42
- Enrollment target
- 1
- Study location
NCT06671652: Completed NA study of Blood Pressure, sponsored by University of Missouri-Columbia.
NCT06671652 is a NA study of Blood Pressure that has completed, run by University of Missouri-Columbia. The registered enrollment target is 42 participants, below the 287-participant average among 101 other Blood Pressure trials with a reported enrollment target (85% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06671652, a NA study of Blood Pressure, has completed, sponsored by University of Missouri-Columbia.
- COMPLETED
- Registry status
- NA
- Development phase
- 42 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a two phase project. Phase I is an online convenience sample to collect health and preference data for the intervention phase, as well as a partnership with community to co-create an intervention; Phase II. Phase II is an intervention to improve community connection and historical knowledge within Cherokee communities within the Cherokee Nation reservation involving consultation with Cherokee cultural and historical experts.
Primary Outcome
Systolic and Diastolic blood pressure measured through millimeters of mercury (mmHG)
Conditions Studied
Interventions
- BEHAVIORAL Duyugoda igalenisodi (Starting again the right way)
Study Locations (1)
Oklahoma
- Cherokee Nation - Tahlequah
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 42 participants |
| Start Date | 2023-09-24 |
| Est. Completion | 2024-06-01 |
| Phase | NA |
What the finished NCT06671652 record still lists
NCT06671652 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 42 participants, a relatively small participant target, below the 287-participant average among 101 other Blood Pressure trials with a reported enrollment target (85% lower).
The record links to 1 condition, with Blood Pressure appearing as the primary indexed condition, and to 1 intervention - of which Duyugoda igalenisodi (Starting again the right way) is the first listed.
NCT06671652 reports a single indexed study location in Oklahoma.
Frequently Asked Questions
What is clinical trial NCT06671652 about?
NCT06671652 is a clinical study titled "Adaptation and Implementation of a Cherokee-based Participatory Research Project to Reduce CVD Risk". This is a two phase project. Phase I is an online convenience sample to collect health and preference data for the intervention phase, as well as a partnership with community to co-create an intervention; Phase II. Phase II is an intervention to improve community connection and historical knowledge ...
What is the current status of trial NCT06671652?
This trial is currently completed. It is a NA study. The enrollment target is 42 participants. The study started on 2023-09-24. Estimated completion is 2024-06-01.
What conditions does trial NCT06671652 study?
This clinical trial studies the following conditions: Blood Pressure.
What interventions are being tested in trial NCT06671652?
The interventions under investigation include: Duyugoda igalenisodi (Starting again the right way) (BEHAVIORAL).
Who is sponsoring clinical trial NCT06671652?
This trial is sponsored by University of Missouri-Columbia, which has 291 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06671652 being conducted?
This trial has 1 study location across Oklahoma. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Blood Pressure
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06671652's enrollment target sits among peer trials
42 66th of 101 higher than 36 of 101 other Blood Pressure trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Blood Pressure trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Ketone Ester And Salt (KEAS) in Older Adults
RECRUITING · NA
-
Cocooned Moms Study
RECRUITING · NA
-
The GUARDIAN Trial
RECRUITING · NA
-
The Venous Distension Reflex and Orthostatic Hypertension
RECRUITING · NA
-
Breaking up Prolonged Sedentary Behavior to Improve Cardiometabolic Health
RECRUITING · NA
-
The Effect of Transcutaneous Stimulation on Blood Pressure in Spinal Cord Injury (SCI)
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02852213 · 42 participants · Phase 1
A Single-Stage, Adaptive, Open-label, Dose Escalation Safety and Efficacy Study of AADC Deficiency in Pediatric Patients
- NCT03136146 · 42 participants · Phase 2
Combination Chemotherapy in Treating Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia, Lymphoblastic Lymphoma, Burkitt Lymphoma/Leukemia, or Double-Hit Lymphoma/Leukemia
- NCT03178149 · 42 participants · Phase 1
A Study of the Safety and Tolerability of ASP7317 in Senior Adults Who Are Losing Their Clear, Sharp Central Vision Due to Geographic Atrophy Secondary to Dry Age-related Macular Degeneration
- NCT03663530 · 42 participants · NA
Circadian Misalignment and Energy Balance
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI